Information Density: Nplate (Amgen) – Signal Evidence & AI Readability

Nplate (Amgen)

(https://nplate.com) 📸 Data Snapshot: May 30, 2026
Information Density — The Lens

Classify each sentence as substantive or hollow. Grounding markers — numbers, currencies, dates, technical units, named entities — outweigh marketing adjectives. When fluff sits right next to hard evidence, the fluff is forgiven.

Info Density Power-words vs. Substance ratio.
20 Impact Weight: 30 / 100
67% Reputation

While the site provides significant technical detail regarding side effects and dosage, its Information Density is compromised by blatant placeholder content. The primary H1 on the homepage ‘Strive for rapid stability and reach for remission’ uses standard clinical power words, but the body text eventually fails forensic inspection. Specifically, the ‘References’ section on the homepage and several sub-pages contains the text ‘TK Drem ipsum dolor sit amet,’ indicating that clinical substance was intended but never actually inserted. This creates a high ratio of fluff-to-substance in the areas where scientific rigor is most expected.

Information Density is read straight from the body copy: how much of the text carries grounded, checkable substance versus hollow filler. Below is the clean text the engine analyzed, then the industry’s known generic-claim patterns to weigh it against.

📝 The Narrative — clean text per page (the substance-vs-filler signal)
HOMEPAGE (https://nplate.com) Immune Thrombocytopenia (ITP) Treatment | Nplate® (romiplostim)
CLOSE

[H3]

Important Safety Information
What is the most important information I should know about Nplate®?
Nplate® can cause serious side effects, including:
Worsening of a precancerous blood condition to a blood cancer (leukemia): Nplate® is not for use in people with a precancerous condition called myelodysplastic syndromes (MDS), or for any condition other than immune thrombocytopenia (ITP). If you have MDS and receive Nplate®, your MDS condition may worsen and become an acute leukemia. If MDS worsens to become acute leukemia you may die sooner from the acute leukemia.

Higher risk for blood clots:
You may have a higher risk of getting a blood clot if your platelet count becomes high during treatment with Nplate®. You may have severe complications or die from some forms of blood clots, such as clots that spread to the legs (Deep Vein Thrombosis), lungs (Pulmonary Embolism) or that cause heart attacks or strokes.
You may get blood clots in the veins of your liver (Portal Vein Thrombosis) with or without chronic liver disease that may affect your liver function.

What are the possible side effects of Nplate®?
Nplate® may cause serious side effects. See “What is the most important information I should know about Nplate®?”
The most common side effects of Nplate® in adults include:
headache
joint pain
dizziness
trouble sleeping
muscle tenderness or weakness
pain in arms and legs
stomach (abdomen) pain
shoulder pain
indigestion
tingling or numbness in hands and feet
bronchitis
inflammation of the sinuses (sinusitis)
vomiting
diarrhea
upper respiratory tract infection
cough
nausea
pain in mouth and throat (oropharyngeal pain)

The most common side effects of Nplate® in children 1 year of age and older include:
bruising
upper respiratory tract infection
pain in mouth and throat (oropharyngeal pain)
headache

People who take Nplate® may have an increased risk of developing new or worsening changes in the bone marrow called “increased reticulin.” These changes may improve if you stop taking Nplate®. Your healthcare provider may need to check your bone marrow for this problem during treatment with Nplate®.
These are not all the possible side effects of Nplate®. Tell your healthcare provider if you have any side effect that bothers you or that does not go away. For more information, ask your healthcare provider or pharmacist.
If you have any questions about this information, be sure to discuss with your doctor. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

How will I receive Nplate®?
Nplate® is given as an injection under the skin (subcutaneous) one time each week by your healthcare provider. Your healthcare provider will check your platelet count every week and change your dose of Nplate® as needed. This will continue until your healthcare provider decides that your dose of Nplate® can stay the same. After that, you will need to get blood tests every month. When you stop receiving Nplate®, you will need blood tests for at least 2 weeks to check if your platelet count drops too low.
APPROVED USES
Nplate® is a prescription medicine used to treat low blood platelet counts (thrombocytopenia) in:
adults with immune thrombocytopenia (ITP) when certain medicines or surgery to remove your spleen have not worked well enough.
children 1 year of age and older with ITP for at least 6 months when certain medicines or surgery to remove your spleen have not worked well enough.
Nplate® is not for use in people with a precancerous condition called myelodysplastic syndrome (MDS), or low platelet count caused by any condition other than immune thrombocytopenia (ITP). Nplate® is only used if your low platelet count and medical condition increase your risk of bleeding. Nplate® is used to try to keep your platelet count about 50,000 per microliter in order to lower the risk for bleeding. Nplate® is not used to make your platelet count normal. It is not known if Nplate® works or if it is safe in people under the age of 1.
Please see Prescribing Information and Medication Guide for more information about Nplate® on Nplate.com.
References
1. TK Drem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.

SEE MORE

[H5]

Important Safety InformationWhat is the most important information I should know about Nplate®?Nplate® can cause serious side effects, including:Worsening of a precancerous blood condition to a blood cancer (leukemia): Nplate® is not for use in people with a precancerous condition called myelodysplastic syndromes (MDS), or for any condition other than immune thrombocytopenia (ITP). If you have MDS and receive Nplate®, your MDS condition may worsen and become an acute leukemia. If MDS worsens to become acute leukemia you may die sooner from the acute leukemia.Higher risk for blood clots:You may have a higher risk of getting a blood clot if your platelet count becomes high during treatment with Nplate®. You may have severe complications or die from some forms of blood clots, such as clots that spread to the lungs or that cause heart attacks or strokes.
5310 chars
SUB-PAGE (https://nplate.com/support/) ITP Support, Resources, Common Questions | Nplate® (romiplostim)
CLOSE

[H3]

Important Safety Information
What is the most important information I should know about Nplate®?
Nplate® can cause serious side effects, including:
Worsening of a precancerous blood condition to a blood cancer (leukemia): Nplate® is not for use in people with a precancerous condition called myelodysplastic syndromes (MDS), or for any condition other than immune thrombocytopenia (ITP). If you have MDS and receive Nplate®, your MDS condition may worsen and become an acute leukemia. If MDS worsens to become acute leukemia you may die sooner from the acute leukemia.

Higher risk for blood clots:
You may have a higher risk of getting a blood clot if your platelet count becomes high during treatment with Nplate®. You may have severe complications or die from some forms of blood clots, such as clots that spread to the legs (Deep Vein Thrombosis), lungs (Pulmonary Embolism) or that cause heart attacks or strokes.
You may get blood clots in the veins of your liver (Portal Vein Thrombosis) with or without chronic liver disease that may affect your liver function.

What are the possible side effects of Nplate®?
Nplate® may cause serious side effects. See “What is the most important information I should know about Nplate®?”
The most common side effects of Nplate® in adults include:
headache
joint pain
dizziness
trouble sleeping
muscle tenderness or weakness
pain in arms and legs
stomach (abdomen) pain
shoulder pain
indigestion
tingling or numbness in hands and feet
bronchitis
inflammation of the sinuses (sinusitis)
vomiting
diarrhea
upper respiratory tract infection
cough
nausea
pain in mouth and throat (oropharyngeal pain)

The most common side effects of Nplate® in children 1 year of age and older include:
bruising
upper respiratory tract infection
pain in mouth and throat (oropharyngeal pain)
headache

People who take Nplate® may have an increased risk of developing new or worsening changes in the bone marrow called “increased reticulin.” These changes may improve if you stop taking Nplate®. Your healthcare provider may need to check your bone marrow for this problem during treatment with Nplate®.
These are not all the possible side effects of Nplate®. Tell your healthcare provider if you have any side effect that bothers you or that does not go away. For more information, ask your healthcare provider or pharmacist.
If you have any questions about this information, be sure to discuss with your doctor. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

How will I receive Nplate®?
Nplate® is given as an injection under the skin (subcutaneous) one time each week by your healthcare provider. Your healthcare provider will check your platelet count every week and change your dose of Nplate® as needed. This will continue until your healthcare provider decides that your dose of Nplate® can stay the same. After that, you will need to get blood tests every month. When you stop receiving Nplate®, you will need blood tests for at least 2 weeks to check if your platelet count drops too low.
APPROVED USES
Nplate® is a prescription medicine used to treat low blood platelet counts (thrombocytopenia) in:
adults with immune thrombocytopenia (ITP) when certain medicines or surgery to remove your spleen have not worked well enough.
children 1 year of age and older with ITP for at least 6 months when certain medicines or surgery to remove your spleen have not worked well enough.
Nplate® is not for use in people with a precancerous condition called myelodysplastic syndrome (MDS), or low platelet count caused by any condition other than immune thrombocytopenia (ITP). Nplate® is only used if your low platelet count and medical condition increase your risk of bleeding. Nplate® is used to try to keep your platelet count about 50,000 per microliter in order to lower the risk for bleeding. Nplate® is not used to make your platelet count normal. It is not known if Nplate® works or if it is safe in people under the age of 1.
Please see Prescribing Information and Medication Guide for more information about Nplate® on Nplate.com.
References
1. TK Drem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.

SEE MORE

[H5]

Important Safety InformationWhat is the most important information I should know about Nplate®?Nplate® can cause serious side effects, including:Worsening of a precancerous blood condition to a blood cancer (leukemia): Nplate® is not for use in people with a precancerous condition called myelodysplastic syndromes (MDS), or for any condition other than immune thrombocytopenia (ITP). If you have MDS and receive Nplate®, your MDS condition may worsen and become an acute leukemia. If MDS worsens to become acute leukemia you may die sooner from the acute leukemia.Higher risk for blood clots:You may have a higher risk of getting a blood clot if your platelet count becomes high during treatment with Nplate®. You may have severe complications or die from some forms of blood clots, such as clots that spread to the lungs or that cause heart attacks or strokes.
5310 chars
SUB-PAGE (https://nplate.com/itp-treatment/) Nplate® Treatment & Platelet Stability | Nplate® (romiplostim)
CLOSE

[H3]

Important Safety Information
What is the most important information I should know about Nplate®?
Nplate® can cause serious side effects, including:
Worsening of a precancerous blood condition to a blood cancer (leukemia): Nplate® is not for use in people with a precancerous condition called myelodysplastic syndromes (MDS), or for any condition other than immune thrombocytopenia (ITP). If you have MDS and receive Nplate®, your MDS condition may worsen and become an acute leukemia. If MDS worsens to become acute leukemia you may die sooner from the acute leukemia.

Higher risk for blood clots:
You may have a higher risk of getting a blood clot if your platelet count becomes high during treatment with Nplate®. You may have severe complications or die from some forms of blood clots, such as clots that spread to the legs (Deep Vein Thrombosis), lungs (Pulmonary Embolism) or that cause heart attacks or strokes.
You may get blood clots in the veins of your liver (Portal Vein Thrombosis) with or without chronic liver disease that may affect your liver function.

What are the possible side effects of Nplate®?
Nplate® may cause serious side effects. See “What is the most important information I should know about Nplate®?”
The most common side effects of Nplate® in adults include:
headache
joint pain
dizziness
trouble sleeping
muscle tenderness or weakness
pain in arms and legs
stomach (abdomen) pain
shoulder pain
indigestion
tingling or numbness in hands and feet
bronchitis
inflammation of the sinuses (sinusitis)
vomiting
diarrhea
upper respiratory tract infection
cough
nausea
pain in mouth and throat (oropharyngeal pain)

The most common side effects of Nplate® in children 1 year of age and older include:
bruising
upper respiratory tract infection
pain in mouth and throat (oropharyngeal pain)
headache

People who take Nplate® may have an increased risk of developing new or worsening changes in the bone marrow called “increased reticulin.” These changes may improve if you stop taking Nplate®. Your healthcare provider may need to check your bone marrow for this problem during treatment with Nplate®.
These are not all the possible side effects of Nplate®. Tell your healthcare provider if you have any side effect that bothers you or that does not go away. For more information, ask your healthcare provider or pharmacist.
If you have any questions about this information, be sure to discuss with your doctor. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

How will I receive Nplate®?
Nplate® is given as an injection under the skin (subcutaneous) one time each week by your healthcare provider. Your healthcare provider will check your platelet count every week and change your dose of Nplate® as needed. This will continue until your healthcare provider decides that your dose of Nplate® can stay the same. After that, you will need to get blood tests every month. When you stop receiving Nplate®, you will need blood tests for at least 2 weeks to check if your platelet count drops too low.
APPROVED USES
Nplate® is a prescription medicine used to treat low blood platelet counts (thrombocytopenia) in:
adults with immune thrombocytopenia (ITP) when certain medicines or surgery to remove your spleen have not worked well enough.
children 1 year of age and older with ITP for at least 6 months when certain medicines or surgery to remove your spleen have not worked well enough.
Nplate® is not for use in people with a precancerous condition called myelodysplastic syndrome (MDS), or low platelet count caused by any condition other than immune thrombocytopenia (ITP). Nplate® is only used if your low platelet count and medical condition increase your risk of bleeding. Nplate® is used to try to keep your platelet count about 50,000 per microliter in order to lower the risk for bleeding. Nplate® is not used to make your platelet count normal. It is not known if Nplate® works or if it is safe in people under the age of 1.
Please see Prescribing Information and Medication Guide for more information about Nplate® on Nplate.com.
References
1. TK Drem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.

SEE MORE

[H5]

Important Safety InformationWhat is the most important information I should know about Nplate®?Nplate® can cause serious side effects, including:Worsening of a precancerous blood condition to a blood cancer (leukemia): Nplate® is not for use in people with a precancerous condition called myelodysplastic syndromes (MDS), or for any condition other than immune thrombocytopenia (ITP). If you have MDS and receive Nplate®, your MDS condition may worsen and become an acute leukemia. If MDS worsens to become acute leukemia you may die sooner from the acute leukemia.Higher risk for blood clots:You may have a higher risk of getting a blood clot if your platelet count becomes high during treatment with Nplate®. You may have severe complications or die from some forms of blood clots, such as clots that spread to the lungs or that cause heart attacks or strokes.
5310 chars
SUB-PAGE (https://nplate.com/platelet-booster/) Nplate® Once-Weekly Platelet Booster | Nplate® (romiplostim)
[H3] Learn about what Nplate® can do for you, how you take it, and how it works.

[H2] What is Nplate®?
Once-weekly Nplate® is a platelet booster that works with your body to create more platelets. Nplate® is used after steroids and does not work by suppressing the immune system. Instead, it increases the activity of the cells that naturally produce platelets.
[IMG: Did you know icon]
For some adults, taking Nplate® may lead to treatment-free remission, meaning platelet counts stay above 50,000 for at least 6 months after stopping ITP treatment

Learn about how Nplate® was studied in adults

[H3] See how Nplate® works

How Nplate® works

Watch the video to see Nplate® in action
Platelets are made by cells in the bone marrow. The amount of platelets your body makes is controlled by a protein called thrombopoietin, or TPO. In people with ITP, the amount of TPO is not high enough.
Nplate® works like TPO, telling the bone marrow to make more platelets, which can help reduce the risk of bleeding in people with ITP.

[H2] Why Nplate®?

[IMG: No known drug interactions or liver monitoring]
[IMG: No known drug interactions or liver monitoring]

NO KNOWN DRUG INTERACTIONS OR LIVER MONITORING

[IMG: Fork, plate, knife]
[IMG: Fork, plate, knife]

EAT WHEN AND WHAT YOU WANT
Can be taken with or without food

[IMG: Ice cream cone]
[IMG: Ice cream cone]

ENJOY CALCIUM-RICH FOODS
LIKE DAIRY

[IMG: Nplate® injection calendar]
[IMG: Nplate® injection calendar]

ONLY ONCE- WEEKLY INJECTION,
No need to remember daily pills

[IMG: 15 years of Nplate® (romiplostim) logo]
[IMG: 15 years of Nplate® (romiplostim) logo]

Nplate® has been proven to BOOST AND SUSTAIN PLATELETS in 5 clinical studies of adults and children with ITP

[H2] Getting Nplate®
[H3] Nplate® is here for you with personalized dosing
Doctors can adjust the amount of Nplate® to find the right dose to keep your platelet levels stable
If your platelet counts stay high enough, your doctor may be able to decrease the amount of Nplate®, or even stop your treatment

[H2] staying on Nplate®

[H3] How long will I be on Nplate®?
Your doctor will help you understand how long you can expect to receive treatment for ITP. It's important to keep your platelets above 50,000 to reduce the risk of bleeding. If your platelets respond well to Nplate®, you may be able to go off treatment.
[IMG: Talk to your doctor about treatment decisions]
It's important to talk to your doctor
about treatment decisions.

[IMG: Two women sitting outside having lunch]
3023 chars
🧭 Industry Context — common generic-claim patterns in Medical Devices, Pharma & Biotech to weigh the text against
Generic Claims: advancing human health, breakthrough innovation, life-changing therapies, transforming patient outcomes, pioneering medical science, the future of medicine…
Red Flags: FDA cleared used interchangeably with FDA approved, clinical claims without published study citations, breakthrough claims for incremental improvements, regulatory status implied but not specified, patient testimonials making efficacy claims, off-label promotion signals…
Semantic Drift Patterns: homepage claims breakthrough but pipeline page shows preclinical only, FDA approved claims but only for one indication, marketed broadly, claims clinical evidence but links to poster presentations not published studies, claims global reach but regulatory approvals are single-market…
Proof Expectations: specific regulatory clearance numbers (FDA 510(k), CE, TGA), published clinical trial results with ClinicalTrials.gov registration, ISO 13485 and GMP certification details, peer-reviewed publication citations, specific patent numbers and status, pharmacovigilance and adverse event reporting mechanisms…